BOB体育 research scientists make medicine better every day. They discover new ways to help
people by running clinical trials. When you join a clinical trial, you can get advanced
medical care. Sometimes years before it's available everywhere. You can also help make
medicine better for everyone else.
If you'd like to learn more about clinical trials, visit our
clinical trials page. Or click one of the links below:
Intravesical BCG vs GEMDOCE in NMIBC (BRIDGE)
The study hypothesis is that BCG na茂ve non-muscle invasive bladder cancer (NMIBC) patients treated with intravesical Gemcitabine + Docetaxel (GEMDOCE) will result in a non-inferior event-free survival (EFS) compared to standard treatment with鈥�
- Investigator
- Padraic O'Malley
- Status
- Accepting Candidates
- Ages
- 18 Years - N/A
- Sexes
- All
Addition of Pembrolizumab to Usual Intravesical Gemcitabine for Treatment of BCG-Unresponsive NMIBC
This phase II trial studies the effect of adding pembrolizumab to gemcitabine in treating patients with non-muscle invasive bladder cancer whose cancer does not respond to Bacillus Calmette-Guerin (BCG) treatment. Chemotherapy drugs, such as鈥�
- Investigator
- Paul L Crispen
- Status
- Accepting Candidates
- Ages
- 18 Years - N/A
- Sexes
- All
BL infusion trial
The study plans to randomize a total of 240 patients infected with Gram-negative bacterial pneumonia to receive beta-lactam (meropenem, cefepime, or piperacillin/tazobactam) continuous or intermittent infusion and collect baseline and regular鈥�
- Status
- Accepting Candidates
- Ages
- 18 Years - 100 Years
- Sexes
- All